BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 16168860)

  • 1. A marginal issue: in regard to Wolden et al. (Int J Radiat Oncol Biol Phys 2005;61:1432-1438).
    Scarbrough TJ; Thomas CR
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):647-8; author reply 648-9. PubMed ID: 16168860
    [No Abstract]   [Full Text] [Related]  

  • 2. Volumetric modulated arc therapy for delivery of prostate radiotherapy: in regard to Palma et al. (Int J Radiat Oncol Biol Phys 2008;70:996-1001).
    Ost P; Fonteyne V; De Neve W; De Gersem W; De Wagter C; Vandecasteele K; Duprez F; De Meerleer G
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1286; author reply 1287. PubMed ID: 19251105
    [No Abstract]   [Full Text] [Related]  

  • 3. In regard to Fiorino et al.: Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer (Int J Radiat Oncol Biol Phys 2003;57:953-962).
    Bauman G; Rodrigues G
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):912-4; author reply 914-5. PubMed ID: 15183497
    [No Abstract]   [Full Text] [Related]  

  • 4. In regard to Lee et al. Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation. (Int J Radiat Oncol Biol Phys 2003;57:49-60).
    Yao M; Dornfeld KJ; Buatti JM
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1639; author reply 1639-40. PubMed ID: 15050350
    [No Abstract]   [Full Text] [Related]  

  • 5. CTV margins in prostate cancer irradiation. In regard to Teh et al.: IMRT for prostate cancer: defining target volume based on correlated pathologic volume of disease (Int J Radiat Oncol Biol Phys 2003;56:184-191).
    Macias V
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):320-1; author reply 321-2. PubMed ID: 15093933
    [No Abstract]   [Full Text] [Related]  

  • 6. In regard to Vicini et al. (Int J Radiat Oncol Biol Phys 2007;68:341-346).
    Rodriguez de Dios N; Bassols ML; Latiesas XS; López MA
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1336-7. PubMed ID: 17967329
    [No Abstract]   [Full Text] [Related]  

  • 7. External beam partial-breast radiotherapy: crucial differences between NYU 00-23 and RTOG 0319: in regard to Vicini et al. (Int J Radiat Oncol Biol Phys 2005;63:1531-1537).
    Formenti SC; Wernicke AG; DeWyngaert JK
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):630; author reply 630-1. PubMed ID: 16966007
    [No Abstract]   [Full Text] [Related]  

  • 8. In regard to Chen et Al. (Int J Radiat Oncol Biol Phys 2007;69:25-31) and Chao et Al. (Int j Radiat Oncol Biol Phys 2007;69:32-40).
    Yaeger TE
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):317; author reply 317-8. PubMed ID: 18406902
    [No Abstract]   [Full Text] [Related]  

  • 9. In regard to Trofimov et al.: Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison (Int J Radiat Oncol Biol Phys 2007;69:444-453).
    Albertini F; Lomax AJ; Hug EB
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1333-4; author reply 1334-5. PubMed ID: 17967323
    [No Abstract]   [Full Text] [Related]  

  • 10. Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer: in regard to Schoenfeld et al. (Int J Radiat Oncol Biol Phys 2008;71:377-385).
    Studer GM; Glanzmann C
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1271-2; author reply 1272. PubMed ID: 18954722
    [No Abstract]   [Full Text] [Related]  

  • 11. In regard to Marcié et al.: in vivo measurements with MOSFET detectors in oropharynx and nasopharynx intensity-modulated radiation therapy (Int J Radiat Oncol Biol Phys 2005;61:1603-1606).
    Ayyangar K; Nehru R; Djajaputra D; Zhen W; Enke C
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):310-1; author reply 311. PubMed ID: 16111605
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomized trial of high- and low-source strength (125)I prostate seed implants: In regard to Narayana et al. (Int J Radiat Oncol Biol Phys 2005;61:44-51).
    Moerland MA; Battermann JJ
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):941-2. PubMed ID: 15936582
    [No Abstract]   [Full Text] [Related]  

  • 13. In regards to: Adjuvant radiotherapy after transoral laser microsurgery for advanced squamous cell carcinoma of the head and neck by Pradier et al. (Int J Radiat Oncol Biol Phys 2005;63:1368-1377).
    Cengiz M; Ozyar E; Genc M
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):955; author reply 955-6. PubMed ID: 16751078
    [No Abstract]   [Full Text] [Related]  

  • 14. Lung V20 measurements: In regard to Seppenwoolde et al. (Int J Radiat Oncol Biol Phys 2003;55:724-735), and Tsujino et al. (Int J Radiat Oncol Biol Phys 2003;56:1208-1209).
    Garces YI; Miller RC
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1636; author reply 1636-7. PubMed ID: 15050346
    [No Abstract]   [Full Text] [Related]  

  • 15. In regard to Kupelian et al.: Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seed/external beam radiotherapy for stage T1-T2 prostate cancer (Int J Radiat Oncol Biol Phys 2004;58:25-33).
    Halperin RM
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):631-2; author reply 632. PubMed ID: 15667989
    [No Abstract]   [Full Text] [Related]  

  • 16. Does image-guided radiotherapy (IG-IMRT) improve toxicity profile in whole pelvic-treated high-risk prostate cancer? Comparison between IG-IMRT and IMRT: In regard to Chung et al. (Int J Radiat Oncol Biol Phys 2008. In press).
    Jothybasu KS; Bahl A; Subramani V; Sharma DN; Rath GK
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1273; author reply 1273. PubMed ID: 18954726
    [No Abstract]   [Full Text] [Related]  

  • 17. Re-irradiation for recurrent head and neck cancer: in regard to Lee et Al. (Int j radiat oncol biol phys 2007;68:731-740).
    Nieder C
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1652-3; author reply 1653. PubMed ID: 18035224
    [No Abstract]   [Full Text] [Related]  

  • 18. Brachytherapy doses for prostate cancer customized to risk factors: is it more important "how much" or "where"? In regard to Stone et al. (Int J Radiat Oncol Biol Phys 2007;69:1472-1477).
    Oton CA; Oton F
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):962; author reply 962-3. PubMed ID: 18514795
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiation dose is predictive of biochemical failure, local failure, and distant metastases. In regard to Kupelian et Al. (Int J Radiat Oncol Biol Phys 2008;71:16-22).
    Kelly P
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1621-2; author reply 1622. PubMed ID: 19028291
    [No Abstract]   [Full Text] [Related]  

  • 20. Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer: in regard to Roh et Al (Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1348-55.
    Yazici G; Cengiz M; Akyol F
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1278; author reply 1278. PubMed ID: 20206031
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.